Digital Technology Linked to Lower Rates of Cognitive Decline in Adults Older Than 50
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, April 17, 2025 -- Widespread use of digital technology seems to be associated with lower rates of cognitive decline in adults older than 50 years, according to a study published online April 14 in Nature Human Behaviour.
Jared F. Benge, Ph.D., from the University of Texas at Austin, and Michael K. Scullin, Ph.D., from Baylor University in Waco, Texas, conducted a systematic review and meta-analysis to examine whether technological exposure has helped or harmed cognition in digital pioneers. Fifty-seven observational or cohort studies focusing on general digital technology use in older adults (older than 50 years) were included in the meta-analysis; 411,430 adults were included from cross-sectional and longitudinal observational studies.
The researchers found an association for use of digital technologies with a reduced risk for cognitive impairment (odds ratio, 0.42) as well as reduced time-dependent rates of cognitive decline (hazard ratio, 0.74). When accounting for demographic, socioeconomic, health, and cognitive reserve proxies, the effects remained significant.
"Technology engagement was associated with reduced odds of cognitive decline in middle-aged and older adults," the authors write. "There was no credible evidence from the longitudinal studies, or the meta-analysis as a whole, for widespread digital 'brain drain' or 'digital dementia' as a result of general, natural uses of digital technology."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-18 12:00
Read more

- Blood Test Can Predict Melanoma Recurrence
- Some Patients Charged Copays for Sending Messages Through Patient Portals
- Mammograms Can Help Assess Women's Heart Health As Well
- New Antibiotic Blujepa May Be Effective in Treating Gonorrhea
- New Guidelines Upped Lung Cancer Screenings, But Gaps Remain
- FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions